| Literature DB >> 11872666 |
Ha-il Kim1, Ji-Young Cha, So-Youn Kim, Jae-woo Kim, Kyung Jin Roh, Je-Kyung Seong, Nam Taek Lee, Kang-Yell Choi, Kyung-Sup Kim, Yong-ho Ahn.
Abstract
Thiazolidinediones, synthetic ligands of peroxisomal proliferator-activated receptor-gamma (PPAR-gamma), improve peripheral insulin sensitivity and glucose-stimulated insulin secretion in pancreatic beta-cells. To explore the role of PPAR-gamma in glucose sensing of beta-cells, we have dissected the beta-cell-specific glucokinase (betaGK) promoter, which constitutes glucose-sensing apparatus in pancreatic beta-cells, and identified a peroxisomal proliferator response element (PPRE) in the promoter. The betaGK-PPRE is located in the region between +47 and +68 bp. PPAR-gamma/retinoid X receptor-alpha heterodimer binds to the element and activates the betaGK promoter. The betaGK promoter lacking or having mutations in PPRE cannot be activated by PPAR-gamma. PPAR-gamma activates the betaGK promoter in beta-cells as well as non-beta-cells. Furthermore, troglitazone increases endogenous GK expression and its enzyme activity in beta-cell lines. These results indicate that PPAR-gamma can regulate GK expression in beta-cells. Taking these results together with our previous work, we conclude that PPAR-gamma regulates gene expression of glucose-sensing apparatus and thereby improves glucose-sensing ability of beta-cells, contributing to the restoration of beta-cell function in type 2 diabetic subjects by troglitazone.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11872666 DOI: 10.2337/diabetes.51.3.676
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461